Guidance to facilitate monitoring and evaluation for AMR national action plans

Overview

This country M&E guidance document was developed as a reference for countries to support the development and delivery of AMR NAPs. It provides assistance on how to establish an M&E plan for their AMR NAP, building on existing national reporting systems and recommended indicators from the GAP-AMR M&E framework. The guidance emphasizes the need for effective governance for AMR NAP development, implementation and monitoring but does not suggest indicators for: a) the GAP-AMR’s fifth strategic objective (investment in research and development) as this was viewed as an aspirational outcome for many countries; and b) indicators specific to HIV, tuberculosis or malaria control programmes, which are monitored and evaluated by those individual disease control programmes.